指南与共识心律失常

2023 ACC/AHA/ACCP/HRS 心房颤动诊断与管理指南

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
指南 / 共识 · J Am Coll Cardiol · 2023-11-30

房颤是最常见的持续性心律失常,其发病率与患病率在美国及全球均呈上升趋势。指南在 2014 版及 2019 聚焦更新基础上,新增房颤与血栓栓塞风险评估、抗凝、左心耳封堵、导管或外科消融、危险因素管理与房颤预防等推荐。

要点

  • 更新房颤患者血栓栓塞风险评估与抗凝管理推荐
  • 新增左心耳封堵及导管或外科消融的推荐条款
  • 强调危险因素管理与房颤预防

核心结论

  • 指南在 2014 版及 2019 聚焦更新基础上,依据新证据更新房颤诊断与管理推荐。
  • 新增房颤与血栓栓塞风险评估、抗凝、左心耳封堵、导管或外科消融、危险因素管理与房颤预防的推荐。

研究设计与样本

  • 由 ACC/AHA/ACCP/HRS 联合制定的临床实践指南。

主要发现

  • 房颤是最常见的持续性心律失常,其发病率与患病率在美国及全球均不断上升。

临床怎么用

  • 为临床医生诊断与管理房颤患者提供推荐依据,覆盖风险评估、抗凝、左心耳封堵、消融及危险因素管理等方面。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. METHODS: A comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" and the "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Joglar, Chung, Armbruster, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023. PMID: 38043043. doi:10.1016/j.jacc.2023.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。